NES
UTHR icon

New England Securities’s United Therapeutics UTHR Stock Holding History

New England Securities’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$10K Hold
77
– – ﹤0.01% 1094
2014
Q3 		$10K Hold
77
– – ﹤0.01% 1114
2014
Q2 		$7K Hold
77
– – ﹤0.01% 1224
2014
Q1 		$7K Sell
77
-10
-11% -$1.02K ﹤0.01% 1183
2013
Q4 		$10K Buy
87
+10
+13% +$902 ﹤0.01% 1036
2013
Q3 		$6K Buy
+77
New +$5.63K ﹤0.01% 1140

Other funds holding UTHR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

New England Securities's UTHR Position: Q4 2014 in Review

New England Securities held its United Therapeutics (UTHR) position steady in Q4 2014 at 77 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

New England Securities first reported a position in UTHR in Q3 2013 and has held it in 6 quarters since. 334 funds tracked by Wall St. Rank hold UTHR as of Q4 2014.

  • New England Securities held 77 shares of United Therapeutics worth $10K as of Q4 2014.
  • New England Securities left its United Therapeutics share count unchanged in Q4 2014.
  • United Therapeutics made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1094 holding.
  • New England Securities first reported a position in United Therapeutics in Q3 2013 and has held it in 6 quarters since.
  • 334 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.